Sulzer Medica postpones shareholders meeting:
This article was originally published in Clinica
Swiss company Sulzer Medica is to postpone an extraordinary shareholders' meeting, planned for December 20, because of the ongoing US litigation over its faulty hip and tibial baseplate products. "We want to know what exactly we are dealing with before presenting the litigation situation to our shareholders and showing them how we will master it," said Max Link, chairman of the board. The company expects to present its strategy for settling the US class action suit in the US at a meeting in the first quarter of 2002. Earlier this month, the company warned it may file for Chapter 11 bankruptcy protection for its US Sulzer Orthopedics division (see Clinica No 984, p 15).